When a clinical trial turns into a win-win game
Her-2 dual blockade strategy in the curative treatment of early breast cancer
2 COMENTÁRIOSHer-2 dual blockade strategy in the curative treatment of early breast cancer
2 COMENTÁRIOSAdjuvant TKI and neoadjuvant immunotherapy blow favorable winds
4 COMENTÁRIOSShould supplementation be considered?
4 COMENTÁRIOSBenefits associated with personalized medicine
1 COMENTÁRIOS